Pharma Journalist - Page 4 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

FDA Rejects Replimune Melanoma Therapy, Citing Data Concerns

Telix and Regeneron Partner on Next-Generation Cancer Therapies

AbbVie Highlights Promising Ovarian Cancer Trial Results at SGO 2026

FDA Grants Priority Review to Lung Cancer Drug Candidate

Novo Nordisk Partners with OpenAI to Accelerate Drug Discovery

4th ADC Linker & Conjugation Summit Announces 2026 Agenda, Bringing Specialist Chemists Together in Boston This July

FDA Reviews Telix Brain Cancer Imaging Drug Application

C4 Therapeutics and Roche Expand Cancer Research Collaboration

AC Immune, Lilly Expand Alzheimer’s Drug Collaboration

Nxera Hits Milestone in Lilly Diabetes Drug Partnership